首页> 外国专利> ANALGESIC AGENT FOR VISCERAL PAIN MANAGEMENT

ANALGESIC AGENT FOR VISCERAL PAIN MANAGEMENT

机译:内脏疼痛的止痛剂

摘要

FIELD: medicine.;SUBSTANCE: what is offered is application of amide N-(6-phenylhexanoyl)glycin-L-triptophane (GB-115, dipeptide, previously known as a psychotropic substance) as an agent for visceral pain management. Evident analgesic activity of the compound is shown in a visceral pain model (writhing test). An analgesic effect of GB-115 is exceeded in efficiency by morphine, nevertheless is comparable in antinociception intensity to the nonsteroidal anti-inflammatory drug diclofenac. Naltrexone iodide, a nonselective peripheral opioid receptor antagonist completely prevents GB-115 from displaying analgesic properties that testifies to GB-115 interaction with peripheral opioid receptors. The k-opioid receptor blockade by norbinaltorphimine, a selective k-receptor antagonist, arrests pharmacological effects of GB-115.;EFFECT: drug is characterised by a unique spectrum of receptor reactions and the absence of side effects, practically nontoxic, does not cause sedation and respiratory depression peculiar to opioid analgesics, does not exhibit ulcerogenic effects and action of a hematosis process inherent in NSAIDs.;6 dwg, 3 tbl
机译:领域:药物;物质:提供酰胺N-(6-苯基己酰基)甘氨酸-L-三苯甲基(GB-115,二肽,以前称为精神药物)作为内脏疼痛管理剂的用途。该化合物的明显镇痛活性显示在内脏痛模型中(扭体试验)。吗啡有效地超过了GB-115的镇痛作用,但其抗伤害感受强度与非甾体类抗炎药双氯芬酸相当。碘化纳曲酮,一种非选择性的外周阿片受体拮抗剂,完全阻止了GB-115的镇痛作用,从而证明了GB-115与外周阿片受体的相互作用。选择性k受体拮抗剂norbinaltorphimine对k阿片受体的阻滞作用可阻止GB-115的药理作用。效果:该药物具有独特的受体反应谱,且无副作用,实际上无毒,不会引起阿片类镇痛药特有的镇静作用和呼吸抑制作用,未表现出致溃疡作用和非甾体抗炎药固有的血肿过程的作用。6dwg,3 tbl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号